Aptorum Group Limited - Class A Ordinary Shares (APM): Price and Financial Metrics

Aptorum Group Limited - Class A Ordinary Shares (APM): $2.66

-0.11 (-3.97%)

POWR Rating

Component Grades














  • APM scores best on the Sentiment dimension, with a Sentiment rank ahead of 97.76% of US stocks.
  • APM's strongest trending metric is Growth; it's been moving down over the last 47 weeks.
  • APM's current lowest rank is in the Growth metric (where it is better than 5.56% of US stocks).

APM Stock Summary

  • With a price/sales ratio of 98.54, Aptorum Group Ltd has a higher such ratio than 96.67% of stocks in our set.
  • With a year-over-year growth in debt of -83.06%, Aptorum Group Ltd's debt growth rate surpasses just 3.28% of about US stocks.
  • Revenue growth over the past 12 months for Aptorum Group Ltd comes in at 137.71%, a number that bests 95.13% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Aptorum Group Ltd, a group of peers worth examining would be ARDX, RDCM, NVMI, SMCI, and FBIO.
  • Visit APM's SEC page to see the company's official filings. To visit the company's web site, go to www.aptorumgroup.com.

APM Valuation Summary

  • APM's price/sales ratio is 99.2; this is 2510.53% higher than that of the median Healthcare stock.
  • Over the past 33 months, APM's price/earnings ratio has gone up 76.
  • Over the past 33 months, APM's price/earnings ratio has gone up 76.

Below are key valuation metrics over time for APM.

Stock Date P/S P/B P/E EV/EBIT
APM 2021-08-31 99.2 2.2 14.3 13.7
APM 2021-08-30 96.3 2.1 13.9 13.3
APM 2021-08-27 95.2 2.1 13.8 13.1
APM 2021-08-26 94.0 2.0 13.6 12.9
APM 2021-08-25 92.9 2.0 13.4 12.8
APM 2021-08-24 92.7 2.0 13.4 12.8

APM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • APM has a Quality Grade of D, ranking ahead of 15.79% of graded US stocks.
  • APM's asset turnover comes in at 0.027 -- ranking 360th of 677 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows APM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 0.027 -0.114 0.220
2019-12-31 0.016 -0.485 -0.814

APM Price Target

For more insight on analysts targets of APM, see our APM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $15.00 Average Broker Recommendation 1.5 (Moderate Buy)

APM Stock Price Chart Interactive Chart >

Price chart for APM

APM Price/Volume Stats

Current price $2.66 52-week high $14.23
Prev. close $2.77 52-week low $1.16
Day low $2.60 Volume 110,005
Day high $2.84 Avg. volume 622,879
50-day MA $2.64 Dividend yield N/A
200-day MA $2.87 Market Cap 90.50M

Aptorum Group Limited - Class A Ordinary Shares (APM) Company Bio

Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.

APM Latest News Stream

Event/Time News Detail
Loading, please wait...

APM Latest Social Stream

Loading social stream, please wait...

View Full APM Social Stream

Latest APM News From Around the Web

Below are the latest news stories about Aptorum Group Ltd that investors may wish to consider to help them evaluate APM as an investment opportunity.

What Kind Of Shareholders Hold The Majority In Aptorum Group Limited's (NASDAQ:APM) Shares?

Every investor in Aptorum Group Limited ( NASDAQ:APM ) should be aware of the most powerful shareholder groups...

Yahoo | July 15, 2021

Aptorum Shares Move Higher After Interim Data From Staphylococcus Aureus Candidate

Aptorum Group Limited (NASDAQ: APM) announces further interim data from its ongoing Phase 1 trial for ALS-4 targeting Staphylococcus aureus. Specifically, two additional cohorts (Cohort C & D) of the single ascending dose portion of the Phase 1 trial in healthy subjects have been completed with no serious adverse events observed. No subjects were dropped out of the studies, and no serious adverse events were observed. Additionally, no clinically relevant changes regarding vital signs, electrocar

Yahoo | July 12, 2021

Aptorum Group Announces Further Positive Interim Results of the Phase 1 Clinical Trial of ALS-4 Targeting Staphylococcus aureus

NEW YORK & LONDON & PARIS, July 12, 2021--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, announces further positive results of its ongoing Phase 1 clinical trial for ALS-4 (a first in-class anti-virulence approach based small molecule targeting Staphylococcus aureus, including, but not limited to Methicillin Resistant Staphylococcus Aureus ("MRSA")). Specifically, two additional cohorts (Cohort

Yahoo | July 12, 2021

Aptorum Group Interview to Air on Bloomberg Television U.S. on the RedChip Money Report

NEW YORK & LONDON & PARIS, July 09, 2021--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced an interview with President and Executive Director Mr. Darren Lui will air on The RedChip Money Report on the Bloomberg Network in the U.S. on Saturday, July 10 at 7 p.m. U.S. Eastern across the United States. The RedChip Money Report a

Yahoo | July 9, 2021

Commvault Named 2021 HPE GreenLake Momentum Partner of the Year

Commvault (NASDAQ: CVLT), a recognized global enterprise leader in Intelligent Data Services across on-premises, cloud and SaaS environments, today announced it has won the 2021 Hewlett Packard Enterprise (HPE) GreenLake Momentum Partner of the Year Award at HPE Discover 2021.

Yahoo | June 22, 2021

Read More 'APM' Stories Here

APM Price Returns

1-mo 9.47%
3-mo -22.45%
6-mo -19.64%
1-year 56.47%
3-year N/A
5-year N/A
YTD 7.69%
2020 -84.42%
2019 4.41%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7696 seconds.